With advancements in multi-omics and high-throughput screening technologies, a more comprehensive elucidation of the interplay among 'GCK-Aβ-neuroinflammation' and their roles in AD pathogenesis will become feasible, particularly when integrating studies using differentiated neuronal models. This evidence concerns the gene GCK and Alzheimer disease.